vs
Side-by-side financial comparison of GSI TECHNOLOGY INC (GSIT) and NEPHROS INC (NEPH). Click either name above to swap in a different company.
GSI TECHNOLOGY INC is the larger business by last-quarter revenue ($6.1M vs $4.7M, roughly 1.3× NEPHROS INC). NEPHROS INC runs the higher net margin — 1.3% vs -49.7%, a 51.0% gap on every dollar of revenue. On growth, NEPHROS INC posted the faster year-over-year revenue change (22.2% vs 12.2%). Over the past eight quarters, NEPHROS INC's revenue compounded faster (15.9% CAGR vs 8.6%).
Triad GSI is an American voting machine vendor based in Xenia, Ohio. Their main products are election-related computer hardware and software for counting ballots, as well as voter registration.
Nephros Inc is a medical technology company that develops and commercializes high-performance water purification systems, infection control products, and renal care solutions. Its offerings are primarily used by hospitals, dialysis clinics, and long-term care facilities across North America to reduce waterborne pathogen risks and improve patient outcomes.
GSIT vs NEPH — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.1M | $4.7M |
| Net Profit | $-3.0M | $62.0K |
| Gross Margin | 52.7% | 58.4% |
| Operating Margin | -113.7% | 0.4% |
| Net Margin | -49.7% | 1.3% |
| Revenue YoY | 12.2% | 22.2% |
| Net Profit YoY | 25.0% | -82.2% |
| EPS (diluted) | $-0.09 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.1M | $4.7M | ||
| Q3 25 | $6.4M | $4.8M | ||
| Q2 25 | $6.3M | $4.4M | ||
| Q1 25 | $5.9M | $4.9M | ||
| Q4 24 | $5.4M | $3.9M | ||
| Q3 24 | $4.5M | $3.5M | ||
| Q2 24 | $4.7M | $3.3M | ||
| Q1 24 | $5.2M | $3.5M |
| Q4 25 | $-3.0M | $62.0K | ||
| Q3 25 | $-3.2M | $337.0K | ||
| Q2 25 | $-2.2M | $237.0K | ||
| Q1 25 | $-2.2M | $558.0K | ||
| Q4 24 | $-4.0M | $349.0K | ||
| Q3 24 | $-5.5M | $183.0K | ||
| Q2 24 | $1.1M | $-289.0K | ||
| Q1 24 | $-4.3M | $-169.0K |
| Q4 25 | 52.7% | 58.4% | ||
| Q3 25 | 54.8% | 61.2% | ||
| Q2 25 | 58.1% | 63.2% | ||
| Q1 25 | 56.1% | 64.7% | ||
| Q4 24 | 54.0% | 64.0% | ||
| Q3 24 | 38.6% | 61.1% | ||
| Q2 24 | 46.3% | 58.8% | ||
| Q1 24 | 51.6% | 62.1% |
| Q4 25 | -113.7% | 0.4% | ||
| Q3 25 | -49.5% | 6.6% | ||
| Q2 25 | -34.6% | 5.6% | ||
| Q1 25 | -38.7% | 11.6% | ||
| Q4 24 | -74.9% | 8.2% | ||
| Q3 24 | -122.7% | 5.9% | ||
| Q2 24 | 23.1% | -9.7% | ||
| Q1 24 | -87.6% | -5.7% |
| Q4 25 | -49.7% | 1.3% | ||
| Q3 25 | -49.4% | 7.1% | ||
| Q2 25 | -35.3% | 5.4% | ||
| Q1 25 | -37.9% | 11.4% | ||
| Q4 24 | -74.4% | 9.0% | ||
| Q3 24 | -120.0% | 5.2% | ||
| Q2 24 | 23.1% | -8.9% | ||
| Q1 24 | -83.9% | -4.8% |
| Q4 25 | $-0.09 | $0.01 | ||
| Q3 25 | $-0.11 | $0.03 | ||
| Q2 25 | $-0.08 | $0.02 | ||
| Q1 25 | $-0.09 | $0.05 | ||
| Q4 24 | $-0.16 | $0.04 | ||
| Q3 24 | $-0.21 | $0.02 | ||
| Q2 24 | $0.04 | $-0.03 | ||
| Q1 24 | $-0.17 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $70.7M | $5.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $83.6M | $10.2M |
| Total Assets | $98.5M | $13.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.7M | $5.4M | ||
| Q3 25 | $25.3M | $5.2M | ||
| Q2 25 | $22.7M | $5.1M | ||
| Q1 25 | $13.4M | $4.1M | ||
| Q4 24 | $15.1M | $3.8M | ||
| Q3 24 | $18.4M | $2.5M | ||
| Q2 24 | $21.8M | $3.1M | ||
| Q1 24 | $14.4M | $3.6M |
| Q4 25 | $83.6M | $10.2M | ||
| Q3 25 | $38.6M | $10.0M | ||
| Q2 25 | $37.4M | $9.6M | ||
| Q1 25 | $28.2M | $9.3M | ||
| Q4 24 | $29.9M | $8.6M | ||
| Q3 24 | $33.3M | $8.2M | ||
| Q2 24 | $38.0M | $7.9M | ||
| Q1 24 | $36.0M | $8.2M |
| Q4 25 | $98.5M | $13.6M | ||
| Q3 25 | $52.0M | $13.2M | ||
| Q2 25 | $50.5M | $12.2M | ||
| Q1 25 | $43.3M | $11.8M | ||
| Q4 24 | $44.1M | $11.2M | ||
| Q3 24 | $47.4M | $10.4M | ||
| Q2 24 | $52.3M | $11.1M | ||
| Q1 24 | $42.5M | $11.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.9M | $230.0K |
| Free Cash FlowOCF − Capex | $-8.2M | — |
| FCF MarginFCF / Revenue | -134.4% | — |
| Capex IntensityCapex / Revenue | 4.9% | — |
| Cash ConversionOCF / Net Profit | — | 3.71× |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.9M | $230.0K | ||
| Q3 25 | $-887.0K | $99.0K | ||
| Q2 25 | $-1.7M | $994.0K | ||
| Q1 25 | $-1.7M | $322.0K | ||
| Q4 24 | $-3.6M | $1.3M | ||
| Q3 24 | $-3.5M | $-623.0K | ||
| Q2 24 | $-4.3M | $-501.0K | ||
| Q1 24 | $-7.1M | $-672.0K |
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-906.0K | — | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-3.6M | — | ||
| Q3 24 | $-3.5M | — | ||
| Q2 24 | $-4.3M | — | ||
| Q1 24 | $-7.2M | — |
| Q4 25 | -134.4% | — | ||
| Q3 25 | -14.1% | — | ||
| Q2 25 | -27.6% | — | ||
| Q1 25 | -28.3% | — | ||
| Q4 24 | -66.1% | — | ||
| Q3 24 | -76.6% | — | ||
| Q2 24 | -92.0% | — | ||
| Q1 24 | -139.0% | — |
| Q4 25 | 4.9% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | — | 3.71× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 4.19× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 3.74× | ||
| Q3 24 | — | -3.40× | ||
| Q2 24 | -3.96× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSIT
| Distribution | $5.6M | 92% |
| Other | $459.0K | 8% |
NEPH
| Products | $4.6M | 98% |
| Other | $108.0K | 2% |
